COST

922.7

-0.28%↓

PG

147.73

-0.13%↓

KO

71.12

+0.04%↑

PM

155.01

-0.13%↓

PEP

145.82

+0.59%↑

COST

922.7

-0.28%↓

PG

147.73

-0.13%↓

KO

71.12

+0.04%↑

PM

155.01

-0.13%↓

PEP

145.82

+0.59%↑

COST

922.7

-0.28%↓

PG

147.73

-0.13%↓

KO

71.12

+0.04%↑

PM

155.01

-0.13%↓

PEP

145.82

+0.59%↑

COST

922.7

-0.28%↓

PG

147.73

-0.13%↓

KO

71.12

+0.04%↑

PM

155.01

-0.13%↓

PEP

145.82

+0.59%↑

COST

922.7

-0.28%↓

PG

147.73

-0.13%↓

KO

71.12

+0.04%↑

PM

155.01

-0.13%↓

PEP

145.82

+0.59%↑

Search

Afya Ltd (Class A)

Uždarymo kaina

SektoriusVartotojų apsauga

14.86 1.85

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

14.36

Max

14.89

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-58M

194M

Pardavimai

-17M

919M

P/E

Sektoriaus vid.

10.014

28.248

Dividendų pajamingumas

1.63

Pelno marža

21.102

EBITDA

-56M

425M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+38.77% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

1.63%

3.46%

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-41M

1.3B

Ankstesnė atidarymo kaina

13.01

Ankstesnė uždarymo kaina

14.86

Naujienos nuotaikos

By Acuity

50%

50%

55 / 148 reitingas Consumer defensive

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bullish Evidence

Afya Ltd (Class A) Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-11-14 17:45; UTC

Uždarbis
Pagrindinės rinkos jėgos

Figure Technology Shares Rise After Higher 3Q Earnings, Revenue

2025-11-14 17:31; UTC

Uždarbis
Pagrindinės rinkos jėgos

American Bitcoin Advances on 3Q Profit, Eric Trump's Crypto Confidence

2025-11-14 16:15; UTC

Pagrindinės rinkos jėgos

Scholar Rock Shares Rise on Renewed Apitegromab Hopes

2025-11-14 23:56; UTC

Įsigijimai, susijungimai, perėmimai

Berkshire Hathaway Bought Alphabet Shares Worth $4.3 Billion in the Third Quarter. Here's What It Sold. -- Barrons.com

2025-11-14 23:02; UTC

Rinkos pokalbiai

Chinese Battery Makers Benefit From U.S. Rising Demand -- Market Talk

2025-11-14 22:35; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

The Score: Tyson, Robinhood, Walmart, Paramount Skydance and More Stocks That Defined the Week -- WSJ

2025-11-14 22:32; UTC

Įsigijimai, susijungimai, perėmimai

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- 2nd Update

2025-11-14 22:29; UTC

Uždarbis

Starbucks Scores on Holiday Sales. It's a Good Sign for the Turnaround. -- Barrons.com

2025-11-14 22:00; UTC

Įsigijimai, susijungimai, perėmimai

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- Update

2025-11-14 21:50; UTC

Rinkos pokalbiai
Uždarbis

Tech, Media & Telecom Roundup: Market Talk

2025-11-14 21:18; UTC

Įsigijimai, susijungimai, perėmimai

Berkshire Buys Shares of Alphabet and Pares Apple Stake -- WSJ

2025-11-14 20:27; UTC

Rinkos pokalbiai

Oil Futures Rise After Ukraine Strikes Russian Port -- Market Talk

2025-11-14 20:23; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Post Weekly Gain -- Market Talk

2025-11-14 20:17; UTC

Įsigijimai, susijungimai, perėmimai

Several State Attorneys General Oppose Railroad Merger -- WSJ

2025-11-14 19:29; UTC

Rinkos pokalbiai
Uždarbis

Applied Materials' F4Q Results Seen as 'Uninspiring' -- Market Talk

2025-11-14 18:44; UTC

Rinkos pokalbiai
Uždarbis

Disney's Growth Now Hinges More on ESPN -- Market Talk

2025-11-14 18:27; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-11-14 18:27; UTC

Rinkos pokalbiai

Morgan Stanley Sees 'Worthy Successor' in Walmart CEO Furner -- Market Talk

2025-11-14 18:20; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Rises by 3 to 417 -- Market Talk

2025-11-14 17:20; UTC

Rinkos pokalbiai
Uždarbis

Auto & Transport Roundup: Market Talk

2025-11-14 17:20; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Health Care Roundup: Market Talk

2025-11-14 17:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2025-11-14 16:51; UTC

Rinkos pokalbiai

Starbucks Gets Holiday Sales Lift -- Market Talk

2025-11-14 16:48; UTC

Rinkos pokalbiai

Gold Slides Amid Selloff, Lower December Fed Rate-Cut Expectations -- Market Talk

2025-11-14 16:38; UTC

Rinkos pokalbiai

Unica Reports Higher Brazilian Sugar and Ethanol Production -- Market Talk

2025-11-14 16:30; UTC

Įsigijimai, susijungimai, perėmimai

Merck Is Paying Up for Flu Biotech as M&A Spree Continues -- Barrons.com

2025-11-14 16:28; UTC

Rinkos pokalbiai

Ukraine Strike on Russian Port Lifts Distillates -- Market Talk

2025-11-14 15:59; UTC

Rinkos pokalbiai

U.S. Natural Gas Inventories Rise More Than Expected -- Market Talk

2025-11-14 15:06; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-11-14 15:06; UTC

Rinkos pokalbiai

Dollar Could Benefit From U.K., French Fiscal Concerns -- Market Talk

Akcijų palyginimas

Kainos pokytis

Afya Ltd (Class A) Prognozė

Kainos tikslas

By TipRanks

38.77% į viršų

12 mėnesių prognozė

Vidutinis 20.33 USD  38.77%

Aukščiausias 24.5 USD

Žemiausias 17.5 USD

Remiantis 4 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Afya Ltd (Class A) kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

4 ratings

3

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

18.968 / 19.56Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Bullish Evidence

Vidutinės trukmės periodas

Bullish Evidence

Ilgalaikis periodas

Strong Bullish Evidence

Rinkos nuotaikos

By Acuity

55 / 148 reitingas Vartotojų apsauga

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Vidutinis

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Afya Ltd (Class A)

Afya Limited operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. Further, it offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.
help-icon Live chat